PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
This Study is to Investigate the Effect of Etanercept in Early Versus Delayed Referral for Management of Rheumatoid Arthritis Patients.
- First Posted Date
- 2020-02-13
- Last Posted Date
- 2023-07-07
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1226
- Registration Number
- NCT04267614
- Locations
- 🇮🇶
Pfizer, Baghdad, Iraq
Study of RV521 in the Treatment of Adult Subjects Who Have Undergone HCT With an URTI With RSV
- Conditions
- RSV InfectionStem Cell Transplant ComplicationsLower Resp Tract Infection
- Interventions
- Drug: RV521 oral tabletDrug: Placebo oral tablet
- First Posted Date
- 2020-02-13
- Last Posted Date
- 2023-05-08
- Lead Sponsor
- Pfizer
- Registration Number
- NCT04267822
A Study To Compare The Effectiveness Of Tofacitinib 11 Mg Once A Day To Tofacitinib 5 Mg Twice A Day
- Conditions
- Arthritis Rheumatoid
- First Posted Date
- 2020-02-12
- Last Posted Date
- 2023-05-22
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 298
- Registration Number
- NCT04267380
- Locations
- 🇺🇸
Pfizer, New York, New York, United States
Effect Of Multiple Dose PF-06700841 On The Pharmacokinetics Of Single Dose Oral Contraceptive Steroids
- Conditions
- Healthy Female Volunteers
- Interventions
- First Posted Date
- 2020-02-12
- Last Posted Date
- 2020-11-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 18
- Registration Number
- NCT04267250
- Locations
- 🇺🇸
Quotient Sciences Screening Office, Coral Gables, Florida, United States
🇺🇸Quotient Sciences-Miami, Miami, Florida, United States
Study to Evaluate the Effect of Repeat-Dose Rifampin on the Pharmacokinetics (PK) of PF-06651600
- First Posted Date
- 2020-02-12
- Last Posted Date
- 2020-09-16
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT04266509
- Locations
- 🇧🇪
Brussels Clinical Research Unit, Brussels, Bruxelles-capitale, Région DE, Belgium
Renal Impairment Study of PF-06700841
- First Posted Date
- 2020-02-07
- Last Posted Date
- 2024-01-22
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 30
- Registration Number
- NCT04260464
- Locations
- 🇺🇸
Prism Research LLC dba Nucleus Network, Saint Paul, Minnesota, United States
🇺🇸Investigational Drug Services (IDS) University of Miami Hospitals and Clinics, Research Pharmacy, Miami, Florida, United States
🇺🇸University of Miami Division of Clinical Pharmacology, Miami, Florida, United States
A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A BOOSTER DOSE OF A GROUP B STREPTOCOCCUS 6 VALENT POLYSACCHARIDE CONJUGATE VACCINE (GBS6) IN HEALTHY ADULTS
- Conditions
- Group B Streptococcal Infections
- Interventions
- Biological: Group B streptoccous 6-valent polysaccharide conjugate vaccine (GBS6)
- First Posted Date
- 2020-02-06
- Last Posted Date
- 2021-10-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 151
- Registration Number
- NCT04258995
- Locations
- 🇺🇸
J. Lewis Research, Inc./ Foothill Family Clinic South, Salt Lake City, Utah, United States
🇺🇸Clinical Research Atlanta, Stockbridge, Georgia, United States
🇺🇸Kentucky Pediatric & Adult Research Inc., Bardstown, Kentucky, United States
Dose Escalation Study of PF-07209326 in Healthy Participants and Participants With Sickle Cell Disease
- Conditions
- HealthySickle Cell Anemia
- Interventions
- Biological: PF-07209326Biological: Placebo
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2023-12-18
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 52
- Registration Number
- NCT04255875
- Locations
- 🇺🇸
Prism Research LLC dba Nucleus Network, Saint Paul, Minnesota, United States
🇺🇸Howard University College of Medicine, Washington, District of Columbia, United States
🇺🇸Lee Health - Golisano Children's Hospital of Southwest Florida, Fort Myers, Florida, United States
A Low Interventional Study to Monitor Activity Using Wearable Sensors in Duchenne Muscular Dystrophy
- Conditions
- Duchenne Muscular Dystrophy (DMD)
- Interventions
- Device: Activity Monitor
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2021-10-15
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 2
- Registration Number
- NCT04254172
- Locations
- 🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States
A Drug-Drug Interaction Study To Estimate The Effect Of Tafamidis On Rosuvastatin Pharmacokinetics
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2020-09-10
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT04253353
- Locations
- 🇧🇪
Brussels Clinical Research Unit, Brussels, Bruxelles-capitale, Région DE, Belgium